ZBIO - Zenas BioPharma, Inc.
NEXT EARNINGS:
May 14, 2026
EPS Est: $-1.35
|
Rev Est: $25.0M
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$37.00
DETAILS
HIGH:
$48.00
LOW:
$19.00
MEDIAN:
$44.00
CONSENSUS:
$37.00
UPSIDE:
105.44%
Market Cap:
804.02M
Volume:
3,260,979
Avg Volume:
877,915
52 Week Range:
6.11-44.6
Sector:
Healthcare
Industry:
Biotechnology
Beta:
-1.91
Last Dividend:
$N/A
Exchange:
NASDAQ
Country:
US
Employees:
130
IPO Date:
2024-09-13
EPS (TTM):
-8.44
P/E Ratio:
-4.30
Revenue (TTM):
10.00M
Total Assets:
383.64M
Total Debt:
79.96M
Cash & Equiv:
110.64M
Rev Growth (5Y):
-90.0%
EPS Growth (5Y):
N/A
FCF Growth (5Y):
N/A
ROCE:
-65.9%
Debt/Equity:
0.33
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2026-03-16 | $-4.54 | $-1.22 | -272.1% | — | $13.3M | — |
| 2026-03-11 | $-1.28 | $-1.00 | -27.8% | $20.0M | $28.8M | -30.4% |
| 2025-11-12 | $-1.22 | $-0.87 | -40.2% | — | $28.8M | — |
| 2025-08-12 | $-1.25 | $-1.02 | -22.5% | — | $3.8M | — |
| 2025-05-15 | $-0.80 | $-1.11 | +27.9% | $10.0M | $1.2M | +700.0% |
| 2025-03-25 | $-3.99 | $-0.92 | -333.7% | $5.0M | — | — |
| 2024-11-12 | $-5.02 | $-9.33 | +46.2% | — | — | — |
| 2024-06-30 | $-0.99 | — | — | — | — | — |
| Metric | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | 10.00M | 5.00M | 50.00M | 0 |
| Net Income | (377.74M) | (156.99M) | (37.12M) | (119.28M) |
| EPS | -8.44 | -3.76 | -0.97 | -3.11 |
| Total Assets | 383.64M | 369.97M | 68.18M | 74.58M |
| Total Debt | 79.96M | 1.00M | 21.11M | 1.53M |
| Cash & Equivalents | 110.64M | 319.74M | 56.86M | 67.21M |
| Operating Cash Flow | (172.33M) | (119.67M) | (30.53M) | (65.65M) |
| Free Cash Flow | (172.35M) | (119.81M) | (30.55M) | (67.85M) |
| FCF per Share | -3.85 | -2.87 | -0.80 | -1.77 |
| Book Value | 242.14M | 312.46M | (225.72M) | (192.29M) |
| Cash & ST Investments | 343.19M | 350.77M | 56.86M | 67.21M |
| ROC Equity | -1.56 | -0.50 | N/A | N/A |